Developer docs
API playgroundTry for free, no card

Search company profiles

Mayo Clinic Ventures

Full company profile

uuid00062rc

Namestring
Mayo Clinic Ventures
Legal namestring
Mayo Foundation for Medical Education and Research
Company typeenum
Private
Founded yearint
1986
Descriptiontext

Mayo Clinic Ventures is the technology commercialization and strategic partnership arm of Mayo Clinic, operating under the Mayo Foundation for Medical Education and Research (MFMER), a nonprofit medical education and research entity headquartered in Rochester, Minnesota. The organization functions as Mayo Clinic's "front door to business," translating the institution's clinical research, intellectual property, and medical expertise into commercial products and services through licensing, startup formation, equity investment, and strategic collaborations. It supports more than 440 startups using Mayo Clinic technology and has deployed over $400M in capital for strategic collaborations and equity investments since inception.

Its core activities are organized around three operational pillars: "Protect and Develop" (intellectual property protection, technology funding, product development), "Launch and Grow" (licensing, startup formation, equity investment), and "Partner and Scale" (strategic collaborations, mergers and acquisitions). Rather than shipping standalone software products, Mayo Clinic Ventures operates a business development ecosystem that brokers access to Mayo Clinic know-how, copyrighted materials, and clinical assets. Revenue is generated primarily through licensing royalties, equity investment returns, and strategic collaboration agreements — a mix that has returned over $1.3B to Mayo Clinic to support clinical practice, education, and research from inception through 2025.

The organization's go-to-market is direct enterprise engagement through its Department of Business Development, complemented by a global technology transfer and licensing program. Customers and partners span healthcare technology startups, pharmaceutical and medical device companies, health systems, and increasingly AI-enabled clinical tooling providers — exemplified by Mayo Clinic's January 2026 investment in OpenEvidence (a $12B-valued AI clinical decision support company). Competitive positioning rests on Mayo Clinic's global brand, its clinical data and physician network, and a deep portfolio of medical IP accumulated over decades of research and practice.

Short descriptiontext

Mayo Clinic Ventures is the technology commercialization arm of Mayo Clinic, licensing intellectual property, forming startups, and making equity investments to translate the institution's medical research into commercial products. It supports 440+ startups and partners with healthcare and AI companies globally.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
51–100
akta.pro rankint
HeadquartersRochester, United States
HQ citystring
Rochester
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
technology commercialization, intellectual property licensing, healthcare innovation, strategic partnerships, equity investments
Industry1 code
1Hospitals, Clinics & Charitable Healthcare Providers
CodeBPAGACABPrimaryYes
NAICS code3 codes
  • Specialty (except Psychiatric and Substance Abuse) Hospitals622310
  • Trusts, Estates, and Agency Accounts525920
  • Portfolio Management and Investment Advice523940
SIC code2 codes
  • Services-Hospitals8060
  • Services-Health Services8000
Product category
Healthcare Technology Commercialization
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model3 records
1Licensing and Technology Transfer
TypeLicensing Royalties
Description

Revenue generated from licensing Mayo Clinic intellectual property and technology to external companies and startups. This includes patented medical technologies, treatment protocols, and clinical innovations.

businessdevelopment.mayoclinic.org
2Equity Investment Returns
TypeSubscription Recurring
Description

Returns from equity investments in startups and companies using Mayo Clinic technology. The organization has deployed over $400M in strategic collaborations and equity investments, with over $1.3B returned to Mayo Clinic supporting practice, education, and research since inception.

businessdevelopment.mayoclinic.org
3Strategic Collaborations
TypeManaged Services
Description

Revenue from strategic partnerships and collaborations with industry partners, including product development agreements and joint ventures focused on healthcare innovation.

businessdevelopment.mayoclinic.org
Marketing channels3 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Technology or R&D, Operations, Marketing or Sales, Infrastructure
GTM typeB2B
B2B
Offering typeServices
Services
Core offering1 text field

Mayo Clinic Ventures (operating as Mayo Clinic's Department of Business Development) is the technology commercialization and strategic partnership arm of Mayo Clinic. It protects and develops Mayo Clinic intellectual property, licenses patented medical technologies and know-how to external companies, forms and funds startups, makes equity investments, and brokers strategic collaborations between Mayo Clinic and industry partners.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 3 values shown
  • $1.3B+ returned to Mayo Clinic supporting practice, education & research since inception
+2 more records
Product overview1 text field

Mayo Clinic Business Development (Mayo Clinic's front door to business) catalyzes healthcare innovation through technology commercialization and strategic partnerships. Their core activities span intellectual property protection and development, technology funding, product development, licensing, startup formation, equity investment, and strategic collaborations. The organization supports over 440 startups using Mayo Clinic technology and has deployed more than $400M in investment capital for strategic collaborations and equity investments. Their services are structured around three pillars: Protect and Develop (IP, technology funding, product development), Launch and Grow (licensing, startup formation, equity investment), and Partner and Scale (strategic collaborations, mergers and acquisitions). Rather than offering standalone software products, they provide a comprehensive business development ecosystem that bridges industry and commercial groups to transform health and medicine.

Product and service5 records
1Protect and Develop
CategoryTechnology Commercialization Services
2Launch and Grow
CategoryLicensing and Investment Services
3Partner and Scale
CategoryStrategic Partnership Services
4Mayo Clinic Know-How Licensing
CategoryIntellectual Property Licensing
5Mayo Clinic Copyrighted Materials
CategoryIntellectual Property Licensing
Scale indicator4 records

Each record includes

Type, Value, Description, Source

Recent move4 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight4 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

The licensing and venture arm of Mass General Brigham; directly comparable as a leading AMC-based tech transfer office commercializing discoveries from a top U.S. hospital system.

TypeDirect peer
Description

Cedars-Sinai's accelerator and innovation engine; closely comparable in running hospital-validated equity and partnership programs for early-stage healthcare companies.

TypeDirect peer
Description

University of Pennsylvania's technology commercialization hub, running IP licensing and startup-creation activities across a healthcare-heavy research portfolio that overlaps Mayo Clinic's therapeutic scope.

TypeDirect peer
Description

Mount Sinai Health System's tech transfer and venture arm; comparable as an AMC-affiliated organization commercializing IP through licensing, sponsored research, and equity in spin-outs.

TypeDirect peer
Description

Duke University's licensing and ventures group; runs the same academic-medical-center-to-commercial-product pipeline (with notable medical IP overlap) as Mayo Clinic Ventures.

TypeDirect peer
Description

Cleveland Clinic's commercialization and spin-out unit; runs a highly analogous model of hospital-validated IP licensing, startup formation, and equity investing out of a major nonprofit academic medical center.

TypeDirect peer
Description

The technology transfer, licensing, and corporate venture arm of Johns Hopkins, operating across the same medtech, biotech, and digital health verticals with comparable IP-licensing and equity-investment mechanics.

TypeDirect peer
Description

UCSF's technology licensing and startup-support organization; comparable because it commercializes a similarly prestigious academic medical center's biomedical IP through licensing and company formation.

TypeDirect peer
Description

Stanford's central tech transfer office; operates the same IP licensing, sponsored research, and startup-formation playbook as Mayo Clinic Ventures, but from an academic-research parent rather than a hospital parent.

TypeDirect peer
Description

Vanderbilt's tech transfer office; comparable model of licensing and startup formation drawn from a major academic medical center's research output.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers2 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles3 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment47 records

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Mayo Clinic Ventures

Healthcare Technology Commercializationventures.mayoclinic.org

Mayo Clinic Ventures is the technology commercialization arm of Mayo Clinic, licensing intellectual property, forming startups, and making equity investments to translate the institution's medical research into commercial products. It supports 440+ startups and partners with healthcare and AI companies globally.

What Mayo Clinic Ventures does

Mayo Clinic Ventures is the technology commercialization and strategic partnership arm of Mayo Clinic, operating under the Mayo Foundation for Medical Education and Research (MFMER), a nonprofit medical education and research entity headquartered in Rochester, Minnesota. The organization functions as Mayo Clinic's "front door to business," translating the institution's clinical research, intellectual property, and medical expertise into commercial products and services through licensing, startup formation, equity investment, and strategic collaborations. It supports more than 440 startups using Mayo Clinic technology and has deployed over $400M in capital for strategic collaborations and equity investments since inception.

Its core activities are organized around three operational pillars: "Protect and Develop" (intellectual property protection, technology funding, product development), "Launch and Grow" (licensing, startup formation, equity investment), and "Partner and Scale" (strategic collaborations, mergers and acquisitions). Rather than shipping standalone software products, Mayo Clinic Ventures operates a business development ecosystem that brokers access to Mayo Clinic know-how, copyrighted materials, and clinical assets. Revenue is generated primarily through licensing royalties, equity investment returns, and strategic collaboration agreements — a mix that has returned over $1.3B to Mayo Clinic to support clinical practice, education, and research from inception through 2025.

The organization's go-to-market is direct enterprise engagement through its Department of Business Development, complemented by a global technology transfer and licensing program. Customers and partners span healthcare technology startups, pharmaceutical and medical device companies, health systems, and increasingly AI-enabled clinical tooling providers — exemplified by Mayo Clinic's January 2026 investment in OpenEvidence (a $12B-valued AI clinical decision support company). Competitive positioning rests on Mayo Clinic's global brand, its clinical data and physician network, and a deep portfolio of medical IP accumulated over decades of research and practice.

Mayo Clinic Ventures firmographics

Firmographics
Name
Mayo Clinic Ventures
Legal name
Mayo Foundation for Medical Education and Research
Website
http://ventures.mayoclinic.org/
Company type
Private
Founded year
1986
Operating status
Operating
Headcount range
51–100 employees
Short description
Mayo Clinic Ventures is the technology commercialization arm of Mayo Clinic, licensing intellectual property, forming startups, and making equity investments to translate the institution's medical research into commercial products. It supports 440+ startups and partners with healthcare and AI companies globally.
Ownership category
akta.pro rank

Mayo Clinic Ventures industry classification

Industry
Product category
Healthcare Technology Commercialization
NAICS
Specialty (except Psychiatric and Substance Abuse) Hospitals (622310), Trusts, Estates, and Agency Accounts (525920), Portfolio Management and Investment Advice (523940)
SIC
Services-Hospitals (8060), Services-Health Services (8000)
akta.pro primary industry
Hospitals, Clinics & Charitable Healthcare Providers (BPAGACAB)

Keywords

  • Technology commercialization
  • Intellectual property licensing
  • Healthcare innovation
  • Strategic partnerships
  • Equity investments

Where Mayo Clinic Ventures is headquartered

Location

Headquarters

HQ city
Rochester
HQ country
United States
HQ region
North America

Offices1 record

Markets served

Mayo Clinic Ventures business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Technology or R&D, Operations, Marketing or Sales, Infrastructure

Revenue model

  1. Licensing and Technology Transfer: Revenue generated from licensing Mayo Clinic intellectual property and technology to external companies and startups. This includes patented medical technologies, treatment protocols, and clinical innovations.
  2. Equity Investment Returns: Returns from equity investments in startups and companies using Mayo Clinic technology. The organization has deployed over $400M in strategic collaborations and equity investments, with over $1.3B returned to Mayo Clinic supporting practice, education, and research since inception.
  3. Strategic Collaborations: Revenue from strategic partnerships and collaborations with industry partners, including product development agreements and joint ventures focused on healthcare innovation.

Go-to-market motion2 records

Distribution channels1 record

Marketing channels3 records

Mayo Clinic Ventures product offering

Product offering

Core offering

Mayo Clinic Ventures (operating as Mayo Clinic's Department of Business Development) is the technology commercialization and strategic partnership arm of Mayo Clinic. It protects and develops Mayo Clinic intellectual property, licenses patented medical technologies and know-how to external companies, forms and funds startups, makes equity investments, and brokers strategic collaborations between Mayo Clinic and industry partners.

Product overview

Mayo Clinic Business Development (Mayo Clinic's front door to business) catalyzes healthcare innovation through technology commercialization and strategic partnerships. Their core activities span intellectual property protection and development, technology funding, product development, licensing, startup formation, equity investment, and strategic collaborations. The organization supports over 440 startups using Mayo Clinic technology and has deployed more than $400M in investment capital for strategic collaborations and equity investments. Their services are structured around three pillars: Protect and Develop (IP, technology funding, product development), Launch and Grow (licensing, startup formation, equity investment), and Partner and Scale (strategic collaborations, mergers and acquisitions). Rather than offering standalone software products, they provide a comprehensive business development ecosystem that bridges industry and commercial groups to transform health and medicine.

Differentiator

Problem solved

Functional benefit

Products and services

  • Protect and Develop
  • Launch and Grow
  • Partner and Scale
  • Mayo Clinic Know-How Licensing
  • Mayo Clinic Copyrighted Materials

Quantifiable outcome

  • $1.3B+ returned to Mayo Clinic supporting practice, education & research since inception
  • +2 more outcomes

Companies that use Mayo Clinic Ventures

Customer profile

Named customers2 records

Segments3 records

Ideal customer profiles3 records

Mayo Clinic Ventures technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Mayo Clinic Ventures partnerships and signals

Strategic signal

Scale indicators4 records

Recent moves4 records

Expansion highlights4 records

Mayo Clinic Ventures competitors and assessment

Company assessment

Direct peers

  • Mass General Brigham Innovation: The licensing and venture arm of Mass General Brigham; directly comparable as a leading AMC-based tech transfer office commercializing discoveries from a top U.S. hospital system.
  • Cedars-Sinai Accelerator: Cedars-Sinai's accelerator and innovation engine; closely comparable in running hospital-validated equity and partnership programs for early-stage healthcare companies.
  • Penn Center for Innovation: University of Pennsylvania's technology commercialization hub, running IP licensing and startup-creation activities across a healthcare-heavy research portfolio that overlaps Mayo Clinic's therapeutic scope.
  • Mount Sinai Innovation Partners: Mount Sinai Health System's tech transfer and venture arm; comparable as an AMC-affiliated organization commercializing IP through licensing, sponsored research, and equity in spin-outs.
  • Duke Office of Licensing & Ventures: Duke University's licensing and ventures group; runs the same academic-medical-center-to-commercial-product pipeline (with notable medical IP overlap) as Mayo Clinic Ventures.
  • Cleveland Clinic Innovations: Cleveland Clinic's commercialization and spin-out unit; runs a highly analogous model of hospital-validated IP licensing, startup formation, and equity investing out of a major nonprofit academic medical center.
  • Johns Hopkins Technology Ventures: The technology transfer, licensing, and corporate venture arm of Johns Hopkins, operating across the same medtech, biotech, and digital health verticals with comparable IP-licensing and equity-investment mechanics.
  • UCSF Innovation Ventures: UCSF's technology licensing and startup-support organization; comparable because it commercializes a similarly prestigious academic medical center's biomedical IP through licensing and company formation.
  • Stanford Office of Technology Licensing: Stanford's central tech transfer office; operates the same IP licensing, sponsored research, and startup-formation playbook as Mayo Clinic Ventures, but from an academic-research parent rather than a hospital parent.
  • Vanderbilt Center for Technology Transfer and Commercialization: Vanderbilt's tech transfer office; comparable model of licensing and startup formation drawn from a major academic medical center's research output.

Market position

Strengths4 records

Weaknesses5 records

Competitive moat5 records

Key risks5 records

Key highlights6 records

Customer concentration

Mayo Clinic Ventures social profiles

Digital presence

Mayo Clinic Ventures financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Mayo Clinic Ventures leadership team

Management profile

Number of profiles

Profiles3 records

Mayo Clinic Ventures funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Mayo Clinic Ventures M&A and investment

M&A and investment

M&A

Investments47 records

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Mayo Clinic Ventures

What does Mayo Clinic Ventures do?

Mayo Clinic Ventures (operating as Mayo Clinic's Department of Business Development) is the technology commercialization and strategic partnership arm of Mayo Clinic. It protects and develops Mayo Clinic intellectual property, licenses patented medical technologies and know-how to external companies, forms and funds startups, makes equity investments, and brokers strategic collaborations between Mayo Clinic and industry partners.

Is Mayo Clinic Ventures a public or private company?

Mayo Clinic Ventures is a private company. It is classified as nonprofit foundation owned and is currently operating.

When was Mayo Clinic Ventures founded?

Mayo Clinic Ventures was founded in 1986. It employs 51 to 100 people.

Where is Mayo Clinic Ventures based?

Mayo Clinic Ventures is headquartered in Rochester, United States, in the North America region.

How does Mayo Clinic Ventures make money?

Three revenue lines are on record. Licensing and Technology Transfer is the primary driver. The others are equity Investment Returns and strategic Collaborations.

Who are Mayo Clinic Ventures's main competitors?

Direct peers on record are Mass General Brigham Innovation, Cedars-Sinai Accelerator, Penn Center for Innovation, Mount Sinai Innovation Partners, Duke Office of Licensing & Ventures, Cleveland Clinic Innovations, Johns Hopkins Technology Ventures, UCSF Innovation Ventures, Stanford Office of Technology Licensing and Vanderbilt Center for Technology Transfer and Commercialization.

Does Mayo Clinic Ventures have an API?

No public API is recorded for Mayo Clinic Ventures.

What industry is Mayo Clinic Ventures in?

Mayo Clinic Ventures's product category is Healthcare Technology Commercialization. Its primary akta.pro industry code is BPAGACAB, Hospitals, Clinics & Charitable Healthcare Providers. Its NAICS code is 622310 and its SIC code is 8060.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
New York PostAI startup known as ‘ChatGPT for doctors’ doubles valuation to $12B in latest funding roundOpenEvidence, an AI startup providing chatbots for physicians trained on medical journals, closed a $250 million funding round led by Thrive Capital and DST, doubling its valuation to $12 billion from $6 billion just months prior. The company has raised $700 million in under a year from investors including Google Ventures, Nvidia, Kleiner Perkins, and Mayo Clinic, with founder Daniel Nadler claiming over 40% of physicians already use the tool. OpenEvidence reported over $100 million in annualized revenue last year and is prioritizing independence over acquisition, with plans to eventually go public once larger AI companies like SpaceX and OpenAI complete their IPOs.Venture Capital Access OnlineJOGO Health Closes $5.5M in Round Led by Hourglass Ventures, Extends Investment Opportunity for Public to Invest Alongside Mayo Clinic VenturesJOGO Health has closed a $5.5 million investment round led by Hourglass Ventures, with participation from Mayo Clinic Ventures. The company is expanding this funding opportunity to retail investors via Wefunder to support its commercial launch and treat chronic pain and neuromuscular disorders.Business Wire BlogJOGO Health Closes $5.5M in Round Led by Hourglass Ventures, Extends Investment Opportunity for Public to Invest Alongside Mayo Clinic VenturesJOGO Health has closed a $5.5 million investment round led by Hourglass Ventures and is extending the opportunity to public retail investors via Wefunder alongside Mayo Clinic Ventures. The company utilizes FDA-cleared, AI-powered wearable technology to treat chronic pain and neuromuscular disorders through neuroplasticity. Proceeds from the capital raise will support JOGO Health's commercial launch and expansion efforts.FinSMEsElysium Health Raises $40M in Series C FinancingElysium Health raised $40M in Series C equity and debt financing led by GISEV Family Office, with participation from Mayo Clinic Ventures and Western Technology Investment. The funds will support product portfolio expansion, customer growth, and additional clinical trials. The company's pipeline includes tests and clinically validated interventions.GlobeNewswireGE Ventures, Mayo Clinic Ventures and DFJ Invest $13.75M in First Software Platform to Accelerate Cancer Cure Process and DeliveryVineti closed a $13.75M Series A round from GE Ventures, Mayo Clinic Ventures, DFJ, and LifeForce Capital. The funds will support its cloud-based platform for cell and gene therapy logistics, manufacturing, and clinical data. The company aims to improve patient access and safety for individualized treatments.FinSMEsLifecode Raises $20.5M in Series A Funding RoundLifecode Inc., a Foster City, California-based molecular diagnostics company, raised $20.5 million in Series A funding led by Sequoia Capital, The Mayo Clinic, and Mayo Ventures. The company, focused on oncology, is CLIA and CAP certified and aims to improve patient care through actionable molecular information.